The Lancet Oncology#health
[Comment] Radiotherapy dose intensification for high-risk prostate cancer—what is gained?translating…
Factuality: 72/100UnknownLancet Publishing
Can a modest increase in radiotherapy dose make a difference for a patient with high-risk prostate cancer? In The Lancet Oncology, Christophe Hennequin and colleagues present results from the GETUG-AFU 18 trial,1 which enrolled 505 patients across 25 centres in France to answer…